BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38726068)

  • 1. Joint modeling of longitudinal and competing risks for assessing blood oxygen saturation and its association with survival outcomes in COVID-19 patients.
    Geraili Z; HajianTilaki K; Bayani M; Hosseini SR; Khafri S; Ebrahimpour S; Javanian M; Babazadeh A; Shokri M
    J Educ Health Promot; 2024; 13():91. PubMed ID: 38726068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.
    Deslandes E; Chevret S
    BMC Med Res Methodol; 2010 Jul; 10():69. PubMed ID: 20670425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is the Effect of Using a Competing-risks Estimator when Predicting Survivorship After Joint Arthroplasty: A Comparison of Approaches to Survivorship Estimation in a Large Registry.
    Cuthbert AR; Graves SE; Giles LC; Glonek G; Pratt N
    Clin Orthop Relat Res; 2021 Feb; 479(2):392-403. PubMed ID: 33105301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital hypoxemia, measured by pulse oximetry, predicts hospital outcomes during the New York City COVID-19 pandemic.
    Lancet EA; Gonzalez D; Alexandrou NA; Zabar B; Lai PH; Hall CB; Braun J; Zeig-Owens R; Isaacs D; Ben-Eli D; Reisman N; Kaufman B; Asaeda G; Weiden MD; Nolan A; Teo H; Wei E; Natsui S; Philippou C; Prezant DJ
    J Am Coll Emerg Physicians Open; 2021 Apr; 2(2):e12407. PubMed ID: 33748809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes Associated With Overestimation of Oxygen Saturation by Pulse Oximetry in Patients Hospitalized With COVID-19.
    Fawzy A; Wu TD; Wang K; Sands KE; Fisher AM; Arnold Egloff SA; DellaVolpe JD; Iwashyna TJ; Xu Y; Garibaldi BT
    JAMA Netw Open; 2023 Aug; 6(8):e2330856. PubMed ID: 37615985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Admission oxygen saturation and all-cause in-hospital mortality in acute myocardial infarction patients: data from the MIMIC-III database.
    Yu Y; Wang J; Wang Q; Wang J; Min J; Wang S; Wang P; Huang R; Xiao J; Zhang Y; Wang Z
    Ann Transl Med; 2020 Nov; 8(21):1371. PubMed ID: 33313116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuously available ratio of SpO
    Lu X; Jiang L; Chen T; Wang Y; Zhang B; Hong Y; Wang J; Yan F
    Respir Res; 2020 Jul; 21(1):194. PubMed ID: 32698822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A SAS macro for the joint modeling of longitudinal outcomes and multiple competing risk dropouts.
    Wang W; Wang W; Mosley TH; Griswold ME
    Comput Methods Programs Biomed; 2017 Jan; 138():23-30. PubMed ID: 27886712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint analysis of longitudinal measurements and spatially clustered competing risks HIV/AIDS data.
    Momenyan S
    Stat Med; 2021 Dec; 40(28):6459-6477. PubMed ID: 34519089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Discrepancy in Pulse Oximetry and Delayed Identification of Treatment Eligibility Among Patients With COVID-19.
    Fawzy A; Wu TD; Wang K; Robinson ML; Farha J; Bradke A; Golden SH; Xu Y; Garibaldi BT
    JAMA Intern Med; 2022 Jul; 182(7):730-738. PubMed ID: 35639368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality.
    Vafadar Moradi E; Teimouri A; Rezaee R; Morovatdar N; Foroughian M; Layegh P; Rezvani Kakhki B; Ahmadi Koupaei SR; Ghorani V
    Am J Emerg Med; 2021 Feb; 40():11-14. PubMed ID: 33333477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint modeling of longitudinal measures of pneumonia and time to convalescence among pneumonia patients: a comparison of separate and joint models.
    Azmeraw S; Wube Y; Lakew D
    Pneumonia (Nathan); 2022 Dec; 14(1):10. PubMed ID: 36566222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending the code in the open-source saemix package to fit joint models of longitudinal and time-to-event data.
    Lavalley-Morelle A; Mentré F; Comets E; Mullaert J
    Comput Methods Programs Biomed; 2024 Apr; 247():108095. PubMed ID: 38422892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial.
    Abdolahi N; Kaheh E; Golsha R; Khodabakhshi B; Norouzi A; Khandashpoor M; Besharat S; Tavassoli S; Livani S; Azimi SA; Gharib MH; Peivandi B; Fazel A; Shirzad-Aski H; Roshandel G
    Trials; 2020 Jun; 21(1):549. PubMed ID: 32560745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage approach for joint modeling of longitudinal measurements and competing risks data.
    Mehdizadeh P; Baghfalaki T; Esmailian M; Ganjali M
    J Biopharm Stat; 2021 Jul; 31(4):448-468. PubMed ID: 33905295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A joint model of longitudinal and competing risks survival data with heterogeneous random effects and outlying longitudinal measurements.
    Huang X; Li G; Elashoff RM
    Stat Interface; 2010; 3(2):185-195. PubMed ID: 21892381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian joint modeling of ordinal longitudinal measurements and competing risks survival data for analysing Tehran Lipid and Glucose Study.
    Baghfalaki T; Kalantari S; Ganjali M; Hadaegh F; Pahlavanzadeh B
    J Biopharm Stat; 2020 Jul; 30(4):689-703. PubMed ID: 32129702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Hypoxemia and Mortality in Patients With COVID-19.
    Xie J; Covassin N; Fan Z; Singh P; Gao W; Li G; Kara T; Somers VK
    Mayo Clin Proc; 2020 Jun; 95(6):1138-1147. PubMed ID: 32376101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.